Ustar Biotechnology

Ustar Biotechnology, based in Hangzhou, China, is a molecular diagnostic company dedicated to developing, manufacturing, and marketing rapid nucleic acid diagnostic products for point-of-care. The company holds fifteen China, U.S., Japan patents for novel molecular technologies, including disposable nucleic acid(NA) extraction device, cross-priming isothermal amplification (CPA), disposable contamination-proof DNA detection device, and reagent glassification. Combining them, Ustar offers pathogen NA detection platforms and SNP/Mutation detection platform that can be transformed into rapid molecular diagnostic kits for Point-of-Care diagnostics or on-spot testing. The isothermal testing requires no PCR machine and molecular lab, enabling molecular testing possible in the low-resources setting with...

Isothermal amplification,rapid nucleic acid detection,snp/mutation detection,and drug resistance detection

Ustar biotechnology operates in the Biotechnology research industry.

Ustar biotechnology's revenue is 11m - 100m

Ustar biotechnology has 11 - 50 employees.